Learn How to Analyze Your Market and Trading Plan

From RJO Futures | Ad

Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.

Download Your FREE Options Trading Strategy Guide today!

RPRX Insider Trading (Royalty Pharma)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.50%

Insider Buying (Last 12 Months): $127,889,531.00

Insider Selling (Last 12 Months): $355,673,317.18

Royalty Pharma Insider Trading History Chart

Royalty Pharma Share Price & Price History

^$40.73

▲ +0.55 (1.37%)

As of 05/14/2021 01:00 AM ET

Days: 30 | 90 | 365

Gain the Knowledge You Need to Successfully Trade Futures Markets

From RJO Futures | Ad

Our Technical Analysis Guide will give you the insight into today’s fast-moving markets. It’s designed to give you a head start in learning the basics of various TA tools and techniques.

Download Your Complimentary Technical Analysis Guide TODAY!

Royalty Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/14/2021	George W Lloyd	EVP	Sell	69,822	$42.13	$2,941,600.86	3,000
4/12/2021	George W Lloyd	EVP	Sell	449	$42.32	$19,001.68	3,000
3/22/2021	James F Reddoch	EVP	Sell	43,927	$46.32	$2,034,698.64	3,000
3/2/2021	George W Lloyd	EVP	Sell	125,000	$46.94	$5,867,500.00	3,000
3/2/2021	Terrance P Coyne	CFO	Sell	100,000	$46.94	$4,694,000.00	1,500
2/25/2021	Henry A Fernandez	Director	Buy	25,700	$46.83	$1,203,531.00	8,713
12/18/2020	Adage Capital Partners Gp, L.L	Major Shareholder	Sell	7,301,050	$43.92	$320,662,116.00
10/20/2020	Rory B Riggs	Director	Sell	463,200	$42.00	$19,454,400.00	463,200
6/18/2020	Adage Capital Partners Gp, L.L	Major Shareholder	Buy	3,000,000	$28.00	$84,000,000.00
6/18/2020	George W Lloyd	EVP	Buy	3,000	$28.00	$84,000.00	3,000
6/18/2020	Pablo G Legorreta	CEO	Buy	20,000	$28.00	$560,000.00
6/18/2020	Terrance P Coyne	CFO	Buy	1,500	$28.00	$42,000.00	1,500
6/18/2020	William E Ford	Director	Buy	1,500,000	$28.00	$42,000,000.00

SEC Filings (Institutional Ownership Changes) for Royalty Pharma (NASDAQ:RPRX)

40.85% of Royalty Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Royalty Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/14/2021	Laurion Capital Management LP	50,000	$2.18M	0.0%	-13.8%	0.008%
5/14/2021	Profund Advisors LLC	6,685	$0.29M	0.0%	-5.4%	0.001%
5/14/2021	Caisse DE Depot ET Placement DU Quebec	18,989	$0.83M	0.0%	N/A	0.003%
5/14/2021	Capital International Investors	16,449,101	$717.51M	0.2%	0.0%	2.709%
5/14/2021	Nomura Asset Management Co. Ltd.	143,260	$6.25M	0.0%	+8.4%	0.024%
5/14/2021	Arrowstreet Capital Limited Partnership	17,900	$0.78M	0.0%	N/A	0.003%
5/14/2021	Public Employees Retirement System of Ohio	171,839	$7.50M	0.0%	+221.4%	0.028%
5/14/2021	Occudo Quantitative Strategies LP	36,173	$1.58M	0.3%	+336.7%	0.006%
5/14/2021	Dimensional Fund Advisors LP	9,441	$0.41M	0.0%	N/A	0.002%
5/14/2021	Vantage Consulting Group Inc	8,705,551	$379.74M	76.2%	-59.5%	1.434%
5/14/2021	APG Asset Management N.V.	14,657	$0.54M	0.0%	N/A	0.002%
5/14/2021	CIBC Asset Management Inc	23,241	$1.01M	0.0%	N/A	0.004%
5/14/2021	TD Asset Management Inc.	152,992	$6.67M	0.0%	+3.9%	0.025%
5/14/2021	Alpha Paradigm Partners LLC	3,045	$0.13M	0.1%	N/A	0.001%
5/14/2021	UBS Asset Management Americas Inc.	517,954	$22.59M	0.0%	N/A	0.085%
5/14/2021	Stifel Financial Corp	5,376	$0.24M	0.0%	N/A	0.001%
5/14/2021	Credit Suisse AG	115,947	$5.06M	0.0%	+32.4%	0.019%
5/14/2021	Gulf International Bank UK Ltd	37,387	$1.63M	0.0%	+376.8%	0.006%
5/13/2021	Franklin Resources Inc.	1,120,505	$48.88M	0.0%	+0.2%	0.185%
5/13/2021	Trexquant Investment LP	31,767	$1.39M	0.1%	N/A	0.005%
5/13/2021	SG Americas Securities LLC	34,399	$1.50M	0.0%	+162.7%	0.006%
5/13/2021	Bank of New York Mellon Corp	853,715	$37.24M	0.0%	+80.6%	0.141%
5/13/2021	Citigroup Inc.	165,335	$7.21M	0.0%	+173.8%	0.027%
5/13/2021	Healthcare of Ontario Pension Plan Trust Fund	4,945	$0.22M	0.0%	N/A	0.001%
5/13/2021	Mirae Asset Global Investments Co. Ltd.	22,481	$0.98M	0.0%	-8.2%	0.004%
5/13/2021	Bank of Montreal Can	123,436	$5.18M	0.0%	-12.1%	0.020%
5/13/2021	Aviva PLC	102,319	$4.46M	0.0%	+202.3%	0.017%
5/13/2021	Korea Investment CORP	1,400	$61K	0.0%	-96.6%	0.000%
5/12/2021	Serengeti Asset Management LP	25,000	$1.09M	0.5%	N/A	0.004%
5/12/2021	Northern Trust Corp	1,305,633	$56.95M	0.0%	+74.7%	0.215%
5/12/2021	Geode Capital Management LLC	1,930,450	$84.06M	0.0%	+54.1%	0.318%
5/12/2021	Prudential Financial Inc.	8,220	$0.36M	0.0%	N/A	0.001%
5/12/2021	Ensign Peak Advisors Inc	31,900	$1.39M	0.0%	+176.0%	0.005%
5/12/2021	Wellington Shields & Co. LLC	93,670	$4.09M	1.5%	-1.1%	0.015%
5/12/2021	Wellington Shields Capital Management LLC	91,640	$4M	0.4%	-2.1%	0.015%
5/12/2021	Essex Investment Management Co. LLC	962	$42K	0.0%	N/A	0.000%
5/12/2021	JPMorgan Chase & Co.	5,795,267	$252.79M	0.0%	-4.7%	0.955%
5/12/2021	Panagora Asset Management Inc.	15,508	$0.68M	0.0%	+116.6%	0.003%
5/12/2021	Sei Investments Co.	93,276	$4.13M	0.0%	+1,445.8%	0.015%
5/12/2021	Sciencast Management LP	7,100	$0.30M	0.1%	N/A	0.001%
5/12/2021	UBS Group AG	444,533	$19.39M	0.0%	+99.3%	0.073%
5/12/2021	Mitsubishi UFJ Trust & Banking Corp	107,685	$4.74M	0.0%	+32.0%	0.018%
5/12/2021	TimesSquare Capital Management LLC	1,415,615	$61.75M	0.5%	-11.9%	0.233%
5/12/2021	Elo Mutual Pension Insurance Co	12,786	$0.56M	0.0%	N/A	0.002%
5/11/2021	Teacher Retirement System of Texas	36,929	$1.61M	0.0%	+255.3%	0.006%
5/11/2021	Horizon Kinetics Asset Management LLC	49,765	$2.17M	0.0%	N/A	0.008%
5/11/2021	Nissay Asset Management Corp Japan ADV	17,929	$0.78M	0.0%	+39.3%	0.003%
5/11/2021	Rockefeller Capital Management L.P.	12,504	$0.55M	0.0%	-9.8%	0.002%
5/11/2021	New York State Common Retirement Fund	371,500	$16.21M	0.0%	+172.2%	0.061%
5/11/2021	Achmea Investment Management B.V.	26,891	$1.17M	0.0%	N/A	0.004%
5/10/2021	Russell Investments Group Ltd.	1,350	$58K	0.0%	-99.0%	0.000%
5/10/2021	Xponance Inc.	14,379	$0.63M	0.0%	+203.4%	0.002%
5/10/2021	Maryland State Retirement & Pension System	24,581	$1.07M	0.0%	N/A	0.004%
5/10/2021	World Asset Management Inc	5,548	$0.24M	0.0%	N/A	0.001%
5/10/2021	State Board of Administration of Florida Retirement System	210,575	$9.19M	0.0%	+742.3%	0.035%
5/10/2021	Principal Financial Group Inc.	27,847	$1.22M	0.0%	+104.9%	0.005%
5/10/2021	Rafferty Asset Management LLC	8,153	$0.36M	0.0%	-28.5%	0.001%
5/10/2021	Robert Wood Johnson Foundation	970,151	$4.23B	21.6%	-75.5%	0.160%
5/7/2021	Advisors Asset Management Inc.	1,904	$83K	0.0%	-33.1%	0.000%
5/7/2021	BlackRock Inc.	13,664,581	$596.05M	0.0%	+50.9%	2.251%
5/7/2021	American International Group Inc.	5,270	$0.23M	0.0%	+166.8%	0.001%
5/7/2021	Harvard Management Co. Inc.	10,714,284	$467.36M	26.1%	-27.1%	1.765%
5/7/2021	Alps Advisors Inc.	7,232	$0.32M	0.0%	N/A	0.001%
5/7/2021	Swiss National Bank	671,700	$29.30M	0.0%	+56.4%	0.111%
5/7/2021	Sumitomo Mitsui DS Asset Management Company Ltd	8,087	$0.35M	0.0%	+27.2%	0.001%
5/6/2021	Arizona State Retirement System	50,359	$2.20M	0.0%	+54.4%	0.008%
5/6/2021	Blueshift Asset Management LLC	5,628	$0.25M	0.0%	N/A	0.001%
5/6/2021	Rhumbline Advisers	296,803	$12.95M	0.0%	+204.8%	0.049%
5/6/2021	Alliancebernstein L.P.	93,087	$4.06M	0.0%	+85.5%	0.015%
5/6/2021	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	36,613	$1.60M	0.0%	+69.0%	0.006%
5/6/2021	Standard Life Aberdeen plc	28,623	$1.25M	0.0%	+180.5%	0.005%
5/6/2021	M&T Bank Corp	12,265	$0.54M	0.0%	+42.2%	0.002%
5/6/2021	Kovitz Investment Group Partners LLC	58,493	$2.55M	0.1%	+0.5%	0.010%
5/5/2021	Los Angeles Capital Management LLC	889,751	$38.81M	0.2%	+240.7%	0.147%
5/4/2021	Victory Capital Management Inc.	3,188,294	$139.07M	0.1%	-14.0%	0.525%
5/3/2021	The Manufacturers Life Insurance Company	193,389	$8.44M	0.0%	-6.7%	0.032%
5/3/2021	Treasurer of the State of North Carolina	117,604	$5.13M	0.0%	+194.0%	0.019%
5/3/2021	Daiwa Securities Group Inc.	15,561	$0.68M	0.0%	-9.0%	0.003%
5/3/2021	Zurcher Kantonalbank Zurich Cantonalbank	29,413	$1.28M	0.0%	+21.2%	0.005%
4/30/2021	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	28,623	$1.25M	0.0%	+49.0%	0.005%
4/29/2021	Hollencrest Capital Management	16,700	$0.73M	0.1%	N/A	0.003%
4/28/2021	Meeder Asset Management Inc.	16,768	$0.73M	0.0%	N/A	0.003%
4/28/2021	DekaBank Deutsche Girozentrale	108,094	$4.62M	0.0%	+29.6%	0.018%
4/28/2021	Comerica Bank	9,617	$0.42M	0.0%	N/A	0.002%
4/27/2021	Illinois Municipal Retirement Fund	5,104	$0.22M	0.0%	N/A	0.001%
4/27/2021	Concorde Asset Management LLC	11,170	$0.49M	0.3%	N/A	0.002%
4/27/2021	Ridgewood Investments LLC	5,423	$0.24M	0.1%	N/A	0.001%
4/26/2021	KBC Group NV	31,602	$1.38M	0.0%	-62.1%	0.005%
4/23/2021	Robeco Institutional Asset Management B.V.	5,279	$0.23M	0.0%	N/A	0.001%
4/23/2021	S&CO Inc.	58,740	$2.56M	0.2%	+1.9%	0.010%
4/22/2021	IBM Retirement Fund	10,956	$0.48M	0.0%	N/A	0.002%
3/12/2021	DekaBank Deutsche Girozentrale	83,428	$4.07M	0.0%	N/A	0.014%
3/9/2021	Amundi Pioneer Asset Management Inc.	1,947,724	$97.48M	0.1%	N/A	0.502%
3/4/2021	Eaton Vance Management	862,140	$43.15M	0.1%	+55.6%	0.222%
3/2/2021	Norges Bank	1,022,571	$51.18M	0.0%	N/A	0.263%
2/25/2021	Hsbc Holdings PLC	18,341	$0.90M	0.0%	+204.0%	0.005%
2/24/2021	Alyeska Investment Group L.P.	763,817	$38.23M	0.6%	+51.6%	0.197%
2/23/2021	Principal Financial Group Inc.	13,591	$0.68M	0.0%	-21.8%	0.004%
2/23/2021	CWA Asset Management Group LLC	144,117	$7.21M	0.8%	N/A	0.037%
2/19/2021	JPMorgan Chase & Co.	6,080,359	$304.32M	0.0%	+62.1%	1.567%

Data available starting January 2016

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio includes royalties on approximately 45 commercial products and 5 development-stage product candidates in various therapeutic areas, such as rare disease, oncology, neurology, infectious disease, cardiology, and diabetes. The company has royalties on various product, such as Cystic fibrosis franchise, including Kalydeco, Orkambi, Symdeko/Symkevi, and Trikafta/Kaftrio; HIV franchise comprising Atripla, Truvada, Emtriva, Complera, Stribild, Genvoya, Descovy, Odefsey, Symtuza, and Biktarvy; Tradjenta, Onglyza, Kombiglyze, Galvus, Eucreas, and Nesina; Tysabri, Imbruvica, Xtandi, Promacta, Farxiga/Onglyza, Prevymis, Emgality, Crysvita, Erleada, IDHIFA, Trodelvy, Nurtec ODT, Tazverik, and Evrysdi; and other products, such as Bosulif, Cimzia, Conbriza/Fablyn/Viviant, Entyvio, Lexiscan, Mircera, Myozyme, Nesina, Priligy, and Soliqua, as well as Tecfidera, Letairis, Lyrica, Remicade, Humira, Prezista, Rotateq, and Thalomid. Royalty Pharma plc was founded in 1996 and is based in New York, New York.

Today's Range

Now: $40.73

$40.25

$41.07

50 Day Range

MA: $42.57

$40.18

$45.09

52 Week Range

Now: $40.73

$34.80

$56.50

Volume

948,513 shs

Average Volume

2,684,287 shs

Market Capitalization

$24.73 billion

P/E Ratio

N/A

Dividend Yield

1.69%

Beta

N/A

Who are the company insiders with the largest holdings of Royalty Pharma?

Royalty Pharma's top insider shareholders include:

Rory B Riggs (Director)
Henry A Fernandez (Director)
George W Lloyd (EVP)
James F Reddoch (EVP)
Terrance P Coyne (CFO)
Adage Capital Partners Gp, LL (Major Shareholder)
Pablo G Legorreta (CEO)
William E Ford (Director)

Who are the major institutional investors of Royalty Pharma?

Royalty Pharma's top institutional investors include:

Capital International Investors — 2.71%
BlackRock Inc. — 2.25%
Harvard Management Co. Inc. — 1.76%
Vantage Consulting Group Inc — 1.43%
JPMorgan Chase & Co. — 0.95%
Victory Capital Management Inc. — 0.53%

Which major investors are selling Royalty Pharma stock?

During the last quarter, RPRX stock was sold by these institutional investors:

Vantage Consulting Group Inc
Harvard Management Co. Inc.
Robert Wood Johnson Foundation
Victory Capital Management Inc.
JPMorgan Chase & Co.
TimesSquare Capital Management LLC
Russell Investments Group Ltd.
KBC Group NV

During the last year, company insiders that have sold Royalty Pharma company stock include:

Rory B Riggs (Director)
Henry A Fernandez (Director)
George W Lloyd (EVP)
James F Reddoch (EVP)
Terrance P Coyne (CFO)

Which major investors are buying Royalty Pharma stock?

Within the last quarter, RPRX stock was bought by institutional investors including:

BlackRock Inc.
Geode Capital Management LLC
Los Angeles Capital Management LLC
Northern Trust Corp
UBS Asset Management Americas Inc.
Bank of New York Mellon Corp
Swiss National Bank
New York State Common Retirement Fund

In the last year, these company insiders have bought Royalty Pharma stock:

Rory B Riggs (Director)
Henry A Fernandez (Director)
George W Lloyd (EVP)
James F Reddoch (EVP)
Terrance P Coyne (CFO)
Adage Capital Partners Gp, LL (Major Shareholder)

Learn How to Analyze Your Market and Trading Plan

From RJO Futures | Ad

Download Your FREE Options Trading Strategy Guide today!